Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk of Metachronous Findings After Detection of Serrated Lesions and High-grade Dysplasia With Surveillance Delay

NCT05355363 is registered in ClinicalTrials.gov with Centre hospitalier de l'Université de Montréal (CHUM) as lead sponsor.

NCT NCT05355363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05355363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk of Metachronous Findings After Detection of Serrated Lesions and High-grade Dysplasia With Surveillance Delay
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Phase
Not applicable
Overall status
Completed
Start date
February 27, 2023
Completion date
December 31, 2025
Enrollment
727 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon adenoma, colorectal cancer